Related Experiment Video

Updated: Aug 18, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer

Youngseon Choi1, James R Baker

  • 1Department of Biomedical Engineering, School of Engineering, Center for Biologic Nanotechnology, University of Michigan, Ann Arbor, Michigan 48109-0648, USA.

Cell Cycle (Georgetown, Tex.)
|April 23, 2005
PubMed

Insights

Researchers developed a DNA-linked dendrimer nanocluster platform for targeted cancer therapy. This system delivers drugs, genetic materials, and imaging agents to cancer cells by targeting folate receptors.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Oncology

Background:

  • Cancer's unique biology necessitates advanced drug delivery systems targeting specific molecular alterations.
  • Existing systems often lack the multifunctionality and targeting precision required for diverse cancer types.

Purpose of the Study:

  • To create a novel, multifunctional drug delivery system using DNA-directed assembly of dendritic polymers.
  • To develop a platform capable of targeting cancer cells that over-express folate receptors.

Main Methods:

  • Conjugation of dendrimers with bio-functional moieties: fluorescein (FITC) and folic acid (FA).
  • Linking of functionalized dendrimers using complementary DNA oligonucleotides to form nanoclusters.
  • Demonstration of DNA-directed assembly for creating targeted nanostructures.

Main Results:

  • Successful production of DNA-linked dendrimer nanoclusters.
  • Demonstrated targeting capability towards cancer cells over-expressing folate receptors.
  • Characterization of the nanocluster platform's size (nanometer scale).

Conclusions:

  • The DNA-linked dendrimer nanocluster platform offers a unique approach for targeted cancer therapy.
  • This platform facilitates the delivery of diverse agents, including drugs, genetic materials, and imaging agents.
  • Potential for developing combinatorial therapeutics and advanced cancer treatment strategies.

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...